Hereditary MDS/Leukemia Panel

New York
Approved


Genes

ANKRD26, CEBPA, DDX41, ETV6, GATA2, IKZF1, PAX5, POT1, RTEL1, RUNX1, SAMD9, SAMD9L, SRP72, TERC, TERT, TINF2, TP53

Conditions

  • Leukemia
  • Myelodysplastic syndrome

Clinical Utility

  • A personal history of myelodysplastic syndrome diagnosed under age 50
  • A personal history of leukemia or myelodysplastic syndrome and a family history of a related hematologic disorder
  • A personal history of leukemia or myelodysplastic syndrome and additional features of a hereditary syndrome
  • Multiple relatives on the same side of the family diagnosed with leukemia, myelodysplastic syndrome and/or other related features.

Lab Method

  • Next-Gen Sequencing
  • Deletion/Duplication Analysis
  • Capillary Sequencing

Test Code

T830

CPT Codes*

81218x1, 81351x1, 81479x1

ABN Required

No

Turnaround Time**

3 weeks

Preferred Specimen

Fibroblasts (separate charge for cell culture may apply)

Alternative Specimen

Buccal Swabs | 2-5 mL Blood - Lavender Top Tube | Extracted DNA

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.